IL6 and diabetes mellitus: Similarly, in a “diabetes-like” condition, the phosphomimetic (148D) HspB4/αA-crystallin mutant had an even greater dampening effect than that of the WT HspB4/αA-crystallin as demonstrated by a greater decrease in the induction of IL-6 (78%), IL-1β (79%), and MCP-1 (83%).